Elevated TIM3 expression on bone marrow T cells drives immune dysfunction in early relapsed blood cancer after allogeneic hematopoietic stem cell transplantation
Abstract Relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the leading cause of treatment failure in patients with hematologic malignancies. To better understand the mechanisms underlying early relapse (ER), we comprehensively explored the expression of inhibitory...
Saved in:
| Main Authors: | Thi Thuy Duong Pham, Su-Young Choi, Jeong Suk Koh, Bu-Yeon Heo, Sang-Woo Lee, Myung-Won Lee, Wonhyoung Seo, Yunseon Jang, Jung-Hyun Park, Deog-Yeon Jo, Seungyeul Yoo, Jaeyul Kwon, Ik-Chan Song |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Experimental Hematology & Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40164-025-00697-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A preclinical study of allogeneic CD19 chimeric antigen receptor double‐negative T cells as an off‐the‐shelf immunotherapy drug against B‐cell malignancies
by: Dan Wang, et al.
Published: (2024-01-01) -
Reduced T and NK Cell Activity in Glioblastoma Patients Correlates with TIM-3 and BAT3 Dysregulation
by: Farah Ahmady, et al.
Published: (2024-10-01) -
Advances in the study of TIM3 in myelodysplastic syndrome
by: Xinyu Guo, et al.
Published: (2025-08-01) -
Graft failure in allogeneic hematopoietic stem cell recipients: diagnosis and treatment
by: U. V. Maslikova, et al.
Published: (2023-03-01) -
Soluble TIM-3, likely produced by myeloid cells, predicts resistance to immune checkpoint inhibitors in metastatic clear cell renal cell carcinoma
by: Ivan Pourmir, et al.
Published: (2025-02-01)